Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Schepens Eye Research Institute scientist selected for Otto Schade Prize

Schepens Eye Research Institute scientist selected for Otto Schade Prize

Acucela to present data on ACU-4429 oral visual cycle modulator for dry AMD at Retina International meeting

Acucela to present data on ACU-4429 oral visual cycle modulator for dry AMD at Retina International meeting

Progress in development of gene therapies for inherited blindness caused by rod degeneration

Progress in development of gene therapies for inherited blindness caused by rod degeneration

StemCells to initiate second clinical trial of HuCNS-SC human neural stem cells in NCL

StemCells to initiate second clinical trial of HuCNS-SC human neural stem cells in NCL

Interim results from QLT's Phase 1b study of QLT091001 for Leber congenital amaurosis

Interim results from QLT's Phase 1b study of QLT091001 for Leber congenital amaurosis

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Scientists use non-viral, synthetic nanoparticle carrier to restores vision

Scientists use non-viral, synthetic nanoparticle carrier to restores vision

BVA unveils wide-view neurostimulator concept, prototype bionic eye

BVA unveils wide-view neurostimulator concept, prototype bionic eye

New research at Tel Aviv University may lay groundwork for retinal implants in people

New research at Tel Aviv University may lay groundwork for retinal implants in people

Scientific revelations discovered during Retina Implant’s first human clinical trial

Scientific revelations discovered during Retina Implant’s first human clinical trial

World through the eyes of a person with eye disease

World through the eyes of a person with eye disease

Retinitis Pigmentosa: Embryonic stem cells for replacement of diseased retinal cells and restoration of sight

Retinitis Pigmentosa: Embryonic stem cells for replacement of diseased retinal cells and restoration of sight

Low Vision of Michigan introduces new device for RP patients

Low Vision of Michigan introduces new device for RP patients

Researchers to test newest implant in restoring vision damaged by disease

Researchers to test newest implant in restoring vision damaged by disease

Researchers develop PEG-POD tool for gene therapy

Researchers develop PEG-POD tool for gene therapy

BIDMC scientists identify new pathway to address the problem of photophobia during migraines

BIDMC scientists identify new pathway to address the problem of photophobia during migraines

RP International benefit "The Eyes of Christmas" to be telecast to 160 million homes

RP International benefit "The Eyes of Christmas" to be telecast to 160 million homes

QLT commences enrollment in QLT091001 Phase Ib trial of LCA pediatric patients

QLT commences enrollment in QLT091001 Phase Ib trial of LCA pediatric patients

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

Study shows gene therapy can restore vision to children with Leber congenital amaurosis

Study shows gene therapy can restore vision to children with Leber congenital amaurosis